Skip to content

ALBANY MOLECULAR RESEARCH INC

CIK 0001065087

← back to feed
Revenue (TTM)
$610.3M
+25.3% YoY Q2 Jul 2017
Net Income (TTM)
−$65.63M
+34.2% YoY Q2 Jul 2017
EPS Diluted (TTM)
−$1.59
+141.7% YoY Q2 Jul 2017
Gross Margin
—
Q2 Jul 2017
Operating Margin
-1.4%
Q2 Jul 2017
Net Margin
-10.8%
Q2 Jul 2017
Free Cash Flow (TTM)
−$7.53M
Q2 Jul 2017
Cash
$42.23M
Q2 Jul 2017
Total Debt
$216.4M
Q2 Jul 2017
Shares Outstanding
43.12M sh
Q2 Jul 2017

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings